These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2038960)

  • 1. Medication and the quality of life.
    Smith M; Juergens J; Jack W
    Am Pharm; 1991 Apr; NS31(4):27-33. PubMed ID: 2038960
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse-drug-reaction monitoring.
    Faich GA
    N Engl J Med; 1986 Jun; 314(24):1589-92. PubMed ID: 3713757
    [No Abstract]   [Full Text] [Related]  

  • 3. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
    Kessler DA
    JAMA; 1993 Jun; 269(21):2765-8. PubMed ID: 8492403
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse drug event reporting. Improving the low US reporting rates.
    Edlavitch SA
    Arch Intern Med; 1988 Jul; 148(7):1499-503. PubMed ID: 3382293
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmarketing follow-up: physicians have key role.
    Goldsmith MF
    JAMA; 1985 Oct; 254(16):2217. PubMed ID: 4046146
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk Evaluation and Mitigation Strategy (REMS): FDA Perspective on What Physicians Need to Know.
    Slatko GH
    Am Fam Physician; 2015 Nov; 92(9):771-2. PubMed ID: 26554468
    [No Abstract]   [Full Text] [Related]  

  • 7. The practitioner's role in detection of adverse drug reactions.
    Soffer A
    Chest; 1984 Dec; 86(6):808-9. PubMed ID: 6548688
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy of the aged: the problem of compliance and the roles of physicians and pharmacists.
    Gryfe CI; Gryfe BM
    J Am Geriatr Soc; 1984 Apr; 32(4):301-7. PubMed ID: 6368654
    [No Abstract]   [Full Text] [Related]  

  • 9. Watching out for public safety.
    Laskin DM
    J Oral Maxillofac Surg; 1993 Sep; 51(9):959. PubMed ID: 8355100
    [No Abstract]   [Full Text] [Related]  

  • 10. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compliance with the therapeutic regimen: necessity for doctor-pharmacist cooperation in the communication of information].
    Grégoire JP
    Union Med Can; 1979 Dec; 108(12):1451-8. PubMed ID: 524543
    [No Abstract]   [Full Text] [Related]  

  • 12. The Même implant creates a scientific storm.
    Spurgeon D
    CMAJ; 1991 Jul; 145(1):54-60. PubMed ID: 2049698
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists and postmarketing restriction of drug products.
    Zellmer WA
    Am J Hosp Pharm; 1992 Jul; 49(7):1677. PubMed ID: 1621721
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing surveillance.
    Oleen MA
    Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing role of pharmacy practice--a clinical perspective.
    Carmichael JM; Cichowlas JA
    Spec Law Dig Health Care Law; 2002 Aug; (280):9-20. PubMed ID: 12235758
    [No Abstract]   [Full Text] [Related]  

  • 17. The practitioner's role in detection of adverse drug reactions.
    Soffer A
    Arch Intern Med; 1985 Feb; 145(2):232-3. PubMed ID: 3838430
    [No Abstract]   [Full Text] [Related]  

  • 18. 'Dear doctor...'--evaluating the impact of risk communication efforts.
    Seligman PJ
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):291-3. PubMed ID: 12812008
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing role of pharmacy practice--a clinical perspective.
    Carmichael JM; Cichowlas JA
    Ann Health Law; 2001; 10():179-90. PubMed ID: 11496588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians must be wary of noncompliance when assessing patients' response to medication.
    Harrison P
    CMAJ; 1994 Nov; 151(9):1328-9. PubMed ID: 7954184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.